肿瘤学与转化医学（英文）2021，Vol.7Issue(4)：160-164,5.DOI:10.1007/s10330-020-0468-8
Efficacy and adverse reactions of apatinib as second-line or later-line treatment in advanced lung cancer
Efficacy and adverse reactions of apatinib as second-line or later-line treatment in advanced lung cancer
Tao Ren 1Yan Wu2
作者信息
- 1. Department of Oncology,The First People's Hospital of Nanning,Nanning 530022,China
- 2. Department of Pharmacy,The First Affiliated Hospital of Xi'an Medical University,Xi'an 710077,China
- 折叠
摘要
关键词
Log-rank regression analysis/apatinib/advanced lung cancer/prognostic factorsKey words
Log-rank regression analysis/apatinib/advanced lung cancer/prognostic factors引用本文复制引用
Tao Ren,Yan Wu..Efficacy and adverse reactions of apatinib as second-line or later-line treatment in advanced lung cancer[J].肿瘤学与转化医学（英文）,2021,7(4):160-164,5.
